This announcement is a separate document:
康龍化成：根據2022年可轉換債券相關特別授權將予發行的額外換股股份的最終數目的公告
PHARMARON: ANNOUNCEMENT ON THE FINAL NUMBER OF ADDITIONAL CONVERSION SHARES TO BE ISSUED UNDER THE 2022 CONVERTIBLE BONDS-RELATED SPECIFIC MANDATE
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.